We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$1.71B
AUM Growth
-$31.5M
Cap. Flow
+$4.63M
Cap. Flow %
0.27%
Top 10 Hldgs %
83.44%
Holding
47
New
9
Increased
3
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$166M
2
META icon
Meta Platforms (Facebook)
META
+$69.7M
3
AFRM icon
Affirm
AFRM
+$22.1M
4
SANA icon
Sana Biotechnology
SANA
+$14.6M
5
TNYA icon
Tenaya Therapeutics
TNYA
+$14.5M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$91.3M
2
ICE icon
Intercontinental Exchange
ICE
+$81.7M
3
AAPL icon
Apple
AAPL
+$81.2M
4
DVA icon
DaVita
DVA
+$49.2M
5
U icon
Unity
U
+$20.5M

Sector Composition

Rank Sector Weight
1 Healthcare 34.02%
2 Communication Services 23.75%
3 Technology 15.62%
4 Consumer Discretionary 13.04%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$267M 15.62%
1,883,445
-551,458
-23% -$81.2M
RPRX icon
2
Royalty Pharma
RPRX
$26.1B
$258M 15.13%
7,142,856
– –
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$242M 14.18%
713,073
+193,617
+37% +$69.7M
LNW
4
DELISTED
Light & Wonder
LNW
$223M 13.04%
2,678,571
– –
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$3.91T
$163M 9.57%
+1,221,400
New +$166M
AFRM icon
6
Affirm
AFRM
$23.5B
$89.8M 5.26%
753,804
+276,383
+58% +$22.1M
ABCL icon
7
AbCellera Biologics
ABCL
$1.62B
$82.3M 4.82%
4,105,095
– –
QQQ icon
8
Invesco QQQ Trust
QQQ
$455B
$36.3M 2.13%
101,448
-774
-0.8% -$285K
RXRX icon
9
Recursion Pharmaceuticals
RXRX
$1.57B
$34.7M 2.04%
1,509,254
– –
IVV icon
10
iShares Core S&P 500 ETF
IVV
$876B
$28.2M 1.65%
65,342
– –
TXG icon
11
10x Genomics
TXG
$5.87B
$27.1M 1.59%
186,143
– –
SANA icon
12
Sana Biotechnology
SANA
$885M
$26.2M 1.54%
1,163,601
+694,852
+148% +$14.6M
RVMD icon
13
Revolution Medicines
RVMD
$40.2B
$18.4M 1.08%
670,382
– –
RLAY icon
14
Relay Therapeutics
RLAY
$4.02B
$17.1M 1%
541,124
– –
RKLB icon
15
Rocket Lab Corp
RKLB
$39.9B
$16.1M 0.95%
+1,000,000
New +$12M
GLD icon
16
SPDR Gold Trust
GLD
$131B
$15.1M 0.89%
91,955
– –
PRAX icon
17
Praxis Precision Medicines
PRAX
$9.07B
$14.4M 0.84%
51,901
– –
PCT icon
18
PureCycle Technologies
PCT
$1.17B
$14.2M 0.83%
1,069,600
– –
TNYA icon
19
Tenaya Therapeutics
TNYA
$168M
$13.9M 0.81%
+673,270
New +$14.5M
GBIO
20
DELISTED
Generation Bio
GBIO
$12.8M 0.75%
51,035
-200
-0.4% -$47.9K
FULC icon
21
Fulcrum Therapeutics
FULC
$248M
$11.6M 0.68%
410,714
– –
KNTE
22
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$11.5M 0.67%
498,001
– –
MEKA
23
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$11.1M 0.65%
+1,000,000
New +$11.1M
PLRX icon
24
Pliant Therapeutics
PLRX
$67.5M
$9.49M 0.56%
562,379
– –
NRIX icon
25
Nurix Therapeutics
NRIX
$2.43B
$9.43M 0.55%
314,762
– –
1
2

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
DE
Diversified Enterprises Wilmington, Delaware $1.83B AUM 16.79% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Harvard Management Company's Q3 2021 Portfolio in Review

As of Q3 2021, Harvard Management Company held 47 positions worth $1.71B, down 1.8% from $1.74B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Harvard Management Company's Q3 2021 filing shows 9 new, 3 increased, 4 reduced and 7 closed positions. Its largest new stake was Alphabet (Google) Class A: 1,221,400 shares worth $163M. The largest sale was Palo Alto Networks, an estimated $91.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 38% a quarter earlier, followed by Communication Services and Technology.

  • Harvard Management Company's largest Q3 2021 buy was Alphabet (Google) Class A: 1,221,400 shares worth $163M.
  • Harvard Management Company added most to Meta Platforms (Facebook) in Q3 2021, an estimated $69.7M increase.
  • Harvard Management Company's biggest Q3 2021 reduction was Apple, cutting an estimated $81.2M.
  • Harvard Management Company fully exited Palo Alto Networks in Q3 2021, selling an estimated $91.3M.
  • Harvard Management Company's ten largest holdings make up 83% of its $1.71B portfolio in Q3 2021.
  • Harvard Management Company opened 9 new positions and closed 7 in Q3 2021.
  • Harvard Management Company's portfolio value fell 1.8% quarter-over-quarter to $1.71B.

Based on Harvard Management Company's 13F filing for Q3 2021, filed 12 Nov 2021.